Shares of Option Care Health OPCH were unchanged after the company reported Q4 results.
Quarterly Results
Earnings per share rose 211.11% year over year to $0.10, which beat the estimate of $0.07.
Revenue of $804,713,000 rose by 11.64% from the same period last year, which beat the estimate of $793,020,000.
Guidance
Option Care Health sees FY21 sales of $3.20 billion-$3.25 billion.
Details Of The Call
Date: Mar 11, 2021
Time: 08:30 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/ymvpuxcc
Recent Stock Performance
Company's 52-week high was at $20.88
Company's 52-week low was at $5.74
Price action over last quarter: Up 25.59%
Company Profile
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.